Cepheid Expects Q3 Revenues In Line with Expectations | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market yesterday that it expects its third-quarter revenues to be roughly $41 million, in line with analysts' consensus estimate of $40.8 million.

The Sunnyvale, Calif.-based firm will report its third-quarter results on Oct. 28, after the close of the market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.